Anavex Life Sciences Corp (AVXL) — Financial Flexibility Index
Anavex Life Sciences Corp (AVXL) has a Financial Flexibility Index of -1.12x as of December 2025. Free cash flow of $-7.15 Million (operating CF $-7.15 Million minus capex $0.00) represents -1% of total liabilities ($6.37 Million). Also explore Anavex Life Sciences Corp (AVXL) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Anavex Life Sciences Corp Financial Flexibility Index (2004–2025)
Historical Financial Flexibility Index trend for Anavex Life Sciences Corp across 22 annual periods. Check asset allocation strategy of Anavex Life Sciences Corp to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Anavex Life Sciences Corp (2004–2025)
Year-by-year free cash flow to debt coverage for Anavex Life Sciences Corp. For the full company profile including market capitalisation, see AVXL market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.36x | $-39.04 Million | $-39.04 Million | $8.95 Million | ▼ -116.8% |
| 2024 | -2.01x | $-30.81 Million | $-30.81 Million | $15.30 Million | ▲ +9.2% |
| 2023 | -2.22x | $-27.79 Million | $-27.79 Million | $12.53 Million | ▲ +6.6% |
| 2022 | -2.37x | $-24.24 Million | $-24.24 Million | $10.21 Million | ▲ +15.7% |
| 2021 | -2.81x | $-30.38 Million | $-30.38 Million | $10.80 Million | ▲ +3.4% |
| 2020 | -2.91x | $-21.29 Million | $-21.29 Million | $7.31 Million | ▲ +20.7% |
| 2019 | -3.68x | $-18.53 Million | $-18.53 Million | $5.04 Million | ▼ -13.5% |
| 2018 | -3.24x | $-12.58 Million | $-12.58 Million | $3.88 Million | ▼ -28.8% |
| 2017 | -2.52x | $-9.02 Million | $-9.02 Million | $3.58 Million | ▲ +13.1% |
| 2016 | -2.89x | $-9.23 Million | $-9.24 Million | $3.19 Million | ▼ -82.2% |
| 2015 | -1.59x | $-4.23 Million | $-4.23 Million | $2.66 Million | ▼ -328.2% |
| 2014 | -0.37x | $-2.66 Million | $-2.66 Million | $7.16 Million | ▼ -36.3% |
| 2013 | -0.27x | $-777.57K | $-777.57K | $2.86 Million | ▲ +53.6% |
| 2012 | -0.59x | $-1.69 Million | $-1.69 Million | $2.89 Million | ▲ +79.3% |
| 2011 | -2.83x | $-3.80 Million | $-3.80 Million | $1.35 Million | ▼ -102.5% |
| 2010 | -1.40x | $-4.59 Million | $-4.59 Million | $3.29 Million | ▼ -113.1% |
| 2009 | -0.65x | $-2.79 Million | $-2.79 Million | $4.27 Million | ▲ +39.1% |
| 2008 | -1.08x | $-2.47 Million | $-2.47 Million | $2.30 Million | ▼ -52.9% |
| 2007 | -0.70x | $-325.25K | $-325.25K | $462.53K | ▲ +39.3% |
| 2006 | -1.16x | $-32.43K | $-32.43K | $28.01K | ▲ +48.8% |
| 2005 | -2.26x | $-61.07K | $-61.07K | $27.00K | ▲ +52.3% |
| 2004 | -4.75x | $-11.89K | $-11.89K | $2.50K | — |